Bristol-Myers Squibb Company
BMY
$47.85
$1.302.79%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.31B | 2.46B | 72.00M | 1.21B | 1.68B |
| Total Depreciation and Amortization | 983.00M | 1.01B | 1.85B | 2.63B | 2.60B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.61B | 356.00M | 1.24B | 41.00M | 421.00M |
| Change in Net Operating Assets | 15.00M | -1.87B | 1.28B | 1.71B | -2.37B |
| Cash from Operations | 3.92B | 1.95B | 4.44B | 5.59B | 2.33B |
| Capital Expenditure | -361.00M | -260.00M | -378.00M | -324.00M | -262.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -285.00M | -78.00M | -47.00M | -348.00M | -1.37B |
| Divestitures | 270.00M | 243.00M | 333.00M | 255.00M | 270.00M |
| Other Investing Activities | -97.00M | -404.00M | -104.00M | 198.00M | 46.00M |
| Cash from Investing | -473.00M | -499.00M | -196.00M | -219.00M | -1.32B |
| Total Debt Issued | 58.00M | 368.00M | -405.00M | 95.00M | 326.00M |
| Total Debt Repaid | -643.00M | -- | 0.00 | -2.75B | -3.13B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.26B | -1.26B | -1.22B | -1.22B | -1.22B |
| Other Financing Activities | 11.00M | -103.00M | -19.00M | 16.00M | -6.00M |
| Cash from Financing | -1.84B | -993.00M | -1.64B | -3.85B | -4.02B |
| Foreign Exchange rate Adjustments | 128.00M | 66.00M | -147.00M | 77.00M | -22.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.74B | 528.00M | 2.45B | 1.60B | -3.04B |